Patents And Regulatory Exclusivities On Inhalers For Asthma And COPD, 1986–2020

The environmental concerns driving another inhaler makeover

(2020) Sarah DeWeerdt   NATURE

Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England

(2019) Alexander J K Wilkinson et al.   BMJ Open

Tertiary patenting on drug–device combination products in the United States

(2018) Reed F Beall et al.   NATURE BIOTECHNOLOGY

Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement

(2018) Minal R. Patel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Systematic Review of Errors in Inhaler Use

(2016) Joaquin Sanchis et al.   CHEST

Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

(2016) Reed F. Beall et al.   PLoS One

Medication adherence and the risk of severe asthma exacerbations: a systematic review

(2014) Marjolein Engelkes et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical and economic impact of non-adherence in COPD: A systematic review

(2013) Job F.M. van Boven et al.   RESPIRATORY MEDICINE

Inhaler Costs and Medication Nonadherence Among Seniors With Chronic Pulmonary Disease

(2010) Peter J. Castaldi et al.   CHEST